source
- Gilead secures another FDA approval for HIV therapy, bolstering lenacapavir portfolioGilead Sciences announced that the U.S. Food and Drug Administration has approved a new HIV treatment, adding to the company's growing portfolio of antiviral drugs. The approval extends the reach o…
- AstraZeneca and Amgen’s Tezspire shows positive results in Phase 3 eosinophilic esophagitis trialAstraZeneca and Amgen continue to co‑develop and co‑commercialize Tezspire, an anti‑inflammatory therapy already approved for asthma and chronic rhinosinusitis. The partners are preparing another F…